• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Introduction to Pharmacology
Introduction to Pharmacology

... 1. relationship of drug response and duration of action 2. duration of action -- length of time a drug continues its effect 3. time-response curve -- plotting results 4. onset of action -- time from drug administration to first observable effect 5. response will continue as long as effective concent ...
Lesson 1: Legal and Illegal Substances
Lesson 1: Legal and Illegal Substances

... methamphetamine [meth], anabolic steroids, heroin, cannabis), which are usually obtained by dishonest or prohibited means (e.g., through drug dealers). Whether or not a drug is legalized is often influenced by political, cultural, and social concerns. For example, tobacco was considered illegal when ...
hjkhkkjkjhk - Manitoba Education
hjkhkkjkjhk - Manitoba Education

... methamphetamine [meth], anabolic steroids, heroin, cannabis), which are usually obtained by dishonest or prohibited means (e.g., through drug dealers). Whether or not a drug is legalized is often influenced by political, cultural, and social concerns. For example, tobacco was considered illegal when ...
Drug discovery from medicinal plants
Drug discovery from medicinal plants

What is a Clinical Trial Registry
What is a Clinical Trial Registry

... It depends on the individual protocol. The OHRP recommends that you allow at least 30 minutes for entering the protocol specific information. Which Clinical Trials should be Registered? The ICMJE wants to ensure public access to all "clinically directive" trials -- trials that test a clinical hypoth ...
Similarities and Differences Between US and Japan as to
Similarities and Differences Between US and Japan as to

PACKAGE INSERT TEMPLATE FOR SIMETHICONE TABLET
PACKAGE INSERT TEMPLATE FOR SIMETHICONE TABLET

... Infant risk cannot be ruled out. Available evidence and/or expert consensus are inconclusive or are inadequate for determining infant risk when used during breastfeeding. Weigh the potential benefits of drug treatment against potential risks before prescribing this drug during breastfeeding. Adverse ...
Tablets issue 13 - Wirral Medicines Management
Tablets issue 13 - Wirral Medicines Management

... As with any medicine, prescribers take full responsibility for their prescribing decision including any risks associated with the use of unlicensed medicines. Another important consideration for prescribers is that specials have not been assessed by the Medicine and Healthcare products Regulatory Ag ...
Name of the meeting
Name of the meeting

... Progress Status  Inventory on Drug Use data “Drug consumption databases in Europe” (last version August 2011: http://www.imi-protect.eu/results.html) ...
Assignments of PGDPSM – July 2015 Batch
Assignments of PGDPSM – July 2015 Batch

... Answers in the form of photocopy or scanned from any source will not be accepted. While solving problems, clearly indicate the question number along with the part being solved. You may also see the videos related to all courses at the following link: http://www.ignou.ac.in/ignou/aboutignou/broadcast ...
Roach: Introduction to Clinical Pharmacology
Roach: Introduction to Clinical Pharmacology

... – Phase I: 20 to 100 volunteers involved ...
The Role of the Practice Pharmacist
The Role of the Practice Pharmacist

Genotyping - Cytochrome P450 (CYP450) For Drug Metabolism
Genotyping - Cytochrome P450 (CYP450) For Drug Metabolism

... good-quality data addressing the questions of whether testing for CYP450 polymorphisms in adults entering SSRI treatment for non-psychotic depression leads to improvement in outcomes, or whether testing results are useful in medical, personal, or public health decision making.” On March 12, 2010, th ...
the scientific value of non-clinical animal studies in drug development
the scientific value of non-clinical animal studies in drug development

Crominet eyedrops, solution ENG SmPC
Crominet eyedrops, solution ENG SmPC

... Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed ...
PPT - Bioinformatics.ca
PPT - Bioinformatics.ca

... • The samples collected will be in limited quantities; access to them will be tightly controlled and will depend on the policy and practices of the ICGC-member project. At least a small percentage of the samples may be shared with international laboratories for the purposes of performing quality con ...
IRB Terms Glossary
IRB Terms Glossary

... Causal Hypothesis: A statement hypothesizing that the independent variable affects the dependent variable in some way. Causal Relationship: A relationship where an independent variable affects a dependent variable in some way. Children: Persons who have not yet attained the legal age for consent to ...
Pharmacy Law and Ethics
Pharmacy Law and Ethics

... A drug may be adulterated either because it is actually adulterated or because it is deemed to be adulterated due to some requirement for proper storage or handling not having been met. The FDCA adopts a take-no-chances approach. It also recognizes the practical difficulties of proving that an artic ...
VIEW PDF - Glaucoma Today
VIEW PDF - Glaucoma Today

... In essence, the development of a drug delivery system involves two products, the active drug and the delivery system. If the system itself provides therapy (eg, a corrective contact lens that releases the drug), then it may be considered a combination product. The US FDA’s regulations for combinatio ...
Recent developments in the vision care industry
Recent developments in the vision care industry

... elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, who are intolerant of or unresponsive to other intraocular pressurelowering medications.The new formulation differs from the original in that it does not contain the preservative benzalkonium ...
Cost comparison of a commonly prescribed Antidepres,sant
Cost comparison of a commonly prescribed Antidepres,sant

... 3780. Tvro other Rs lz63-q(Elopram l0mg product the cheapest ...
Introduction - Harvard DASH
Introduction - Harvard DASH

... regarding the safety and efficacy of certain antidepressants. They assert that the long-term effects of antidepressant use are alarming, and they blame FDA for not acting more quickly to warn the public of such effects. There have also arisen concerns that antidepressant use may cause suicidal and o ...
Analytical Method Validation Develop Protocols that Survive the
Analytical Method Validation Develop Protocols that Survive the

... Define Intended Use • Identify critical process steps and related assays • Is this used for characterization only? – Or will this lead to a testing requirement and be held to a specification? • How important is continued characterization testing? – Do they need to be ongoing as part of release or u ...
Access OpenFDA: A Cloud Based Big Data Portal Using SAS®
Access OpenFDA: A Cloud Based Big Data Portal Using SAS®

... professionals, easy access to valuable FDA public data, making it simpler for them to use this data in their work to advance and promote the public health. The initiative leverages new technologies and methods such as cloud computing and open source software to unlock the tremendous public data and ...
Moving mountains to serve cancer patients
Moving mountains to serve cancer patients

... caused by oxidative stress, alkylating agents, and ionizing radiation ...
< 1 ... 73 74 75 76 77 78 79 80 81 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report